Primary Aldosteronism: an update on the management
description
Transcript of Primary Aldosteronism: an update on the management
Primary Aldosteronism: an update on the management
Dr Man Chi Mei Vivian
Queen Mary Hospital
Content
• Background information
• Diagnostic algorithms
• Localization and subtype differentiation
• Management
Case Scenario
• 60/M , good past health • Blood test confirmed primary aldosteronism
7mm left adrenal nodule17mm right adrenal nodule
What should be the management?
• Adrenalectomy– Right adrenalectomy?– Left adrenalectomy?– Bilateral adrenalectomy?
• Medical therapy with aldosterone receptor antagonist
Background• First described in 1954
• Group of disorders in which aldosterone production is inappropriately high, relatively autonomous, and non-suppressible by sodium loading1
• Estimated prevalence of 11.2% in hypertensives2
• Hypokalemia not always present– 52% aldosterone-producing adenoma– 83.1% bilateral adrenal hyperplasia
Jerome W. Conn (1907-1994)
1 J Clin Endocrinol Metab 93:3266-3281, 20082 Rossi et al. JACC vol. 48, No. 11. 2006: 2293-300
Types of Primary Aldosteronism
Types Approximate prevalence %
Aldosterone-producing adenoma 30
Bilateral idiopathic hyperaldosteronism 65
Primary adrenal hyperplasia <2
Aldosterone-producing adrenocortical carcinoma
1
Aldosterone-producing ovarian tumor <1
Familial hyperaldosteronism <2
Role for adrenal venous sampling in primary aldosteronism. Young WF et al. Surgery. December 2004.
Diagnosis of primary aldosteronism
• Screening– Aldosterone/ renin ratio (ARR)– Plasma aldosterone concentration (PAC)– Elevated ARR >20ng/dl per ng/ml/h and PAC
>10ng/dL
• Confirmation– Intravenous saline load/ oral salt load– Captopril challenge test– Fludro-cortisone suppression test
Lateralization and subtype differentiation
• Computed tomography (CT)
• Adrenal scintigraphy
• Adrenal venous sampling (AVS)
Computed tomography
Young WF et al. The incidentally discovered adrenal mass. New England Journal of Medicine 2007; 356: 601-10
Adrenocortical adenomaAdrenocortical carcinoma
Young WF et al. The incidentally discovered adrenal mass. New England Journal of Medicine 2007; 356: 601-10
Lateralization and subtype differentiation
• Computed tomography (CT)
• Adrenal scintigraphy
• Adrenal vein sampling (AVS)
Adrenal Scintigraphy• Provides functional information• 131I-6β-iodomethyl-19-norcholesterol (NP-59)• Marker of adreno-cortical uptake
Huang YE et al. Role of 131I-NP-59 Adrenal Imaging in Patients ofACTH-Independent Cushing’s Syndrome. Ann Nucl Med Sci 2001;14:75-83
Chen YC et al. Use of NP-59 SPECT/ CT imaging in atypical primary aldosteronism. Q J Med (2013)
Lateralization and subtype differentiation
• Computed tomography (CT)
• Adrenal scintigraphy
• Adrenal venous sampling (AVS)
Adrenal vein sampling
• First proposed in 1967 as a test to distinguish between aldosterone-producing adenoma and idiopathic hyperaldosteronism
• Gold standard for lateralization of disease
• Femoral venous access• Simultaneously left and right adrenal venous
sampling • Blood aldosterone and cortisol level
Kahn SL et al. Adrenal vein sampling. Techniques in vascular and interventional radiology 13: 110-125
Interpretation
• Confirmation of correct position of adrenal catheters:– Cortisol level from adrenal catheters being 5-10 times
the value obtained from peripheral sheath
• Asymmetrical aldosterone: cortisol values on the affected side being 3-5 times the value obtained from the unaffected side
Kahn SL et al. Adrenal vein sampling. Techniques in vascular and interventional radiology 13: 110-125
Right adrenal vein catheterizationLeft adrenal vein catheterization
Kahn SL et al. Adrenal vein sampling. Techniques in vascular and interventional radiology 13: 110-125
Lau JHG et al . Clinical Endocrinology (2010) 76; 182-188
Diagnostic values and accuracy
• 203 patients were selected for AVS from 1990-2003
• 194 patients underwent successful adrenal vein cannulation– Success rate 95.6%
• Computed tomography, AVS and histopathological findings were compared
Young WF et al. Role of adrenal venous sampling in primary aldosteronism. Surgery 2004; 136: 1227-35
Discordant between CT and AVS
• 110 patients (56.7%) had unilateral source for aldosterone hyper-secretion
Young WF et al. Role of adrenal venous sampling in primary aldosteronism. Surgery 2004; 136: 1227-35
Normal CT scan 24
Bilateral micronodule 16
Bilateral macronodule 2
Unilateral micronodule 7/31 contralateral gland
Unilateral macronodule 1/22 contralateral gland
Combination of micronodule and macronodule
11/18 macronodule
4/18 micronodule
Discordant between CT and AVS• 21.7% (42 patients)
would have been incorrectly excluded as candidates for adrenalectomy
• 24.7% (48 patients) might have unnecessary or inappropriate adrenalectomy
Young WF et al. Role of adrenal venous sampling in primary aldosteronism. Surgery 2004; 136: 1227-35
Discordant between CT/MRI and AVS
• Systematic review of 38 studies, 950 patients included– 37.8% discordance between CT/MRI and AVS– 14.6% inappropriate adrenalectomy – 19.1% inappropriate exclusion from
adrenalectomy– 3.9% adrenalectomy on wrong side
Kempers MJE et al. Systematic Review: Diagnostic Procedures to Differentiate Unilateral From Bilateral Adrenal Abnormality in Primary Aldosteronism. Annals of Internal Medicine, 09/2009, Volume 151, Issue 5, pp. 329 - 337
Computed tomography
Adrenal venous sampling
NP-59 adrenal scintigraphy
•Easily available •Technically demanding
•expertise required
•Requirement of radio-labeled material
•3-5 day test
•Non-invasive •Invasive
•complication rate ~2.5%3
•Non-invasive
•Good resolution •Limited spatial resolution
•Improved with NP-59 SPECT/CT
•Sensitivity 77%1
•Specificity 80%1
•Accuracy improved if discrete unilateral macronodule
•Sensitivity 95%4
•Specificity 100%4
•Planar scintigraphy sensitivity as low as 40%2
•Sensitivity increased to 81.8% when combined with CT2
1. Lau JHG et al . Clinical Endocrinology (2010) 76; 182-1882. Yen RF et al. The Journal of Nuclear Medicine (2009) 50; 10: 1631-16373. Young WF et al. Surgery (2004) 136; 6; 1227-12344. Tsai YS et al. Formos J Endocrin Metab 2011; 2(2): 38-43
Kahn SL et al. Adrenal vein sampling. Techniques in vascular and interventional radiology 13: 110-125
Management
• Bilateral idiopathic hyperaldosteronism– Medical treatment: aldosterone receptor antagonist– Intolerance/ refractory cases: bilateral adrenalectomy
• Aldosterone producing adenoma• Primary adrenal hyperplasia
– Adrenalectomy (laparoscopic/ open)
• Emerging therapies: – Acetic acid injection– Radiofrequency ablation
Moo TA et al. Prediction of Successful Outcome in Patients with Primary Aldosteronism. Current treatment options in oncology (2007) 8:314-321
Back to our patient
• Adrenal to peripheral cortisol level:– Right side: 3.6 versus left side: 3.2
• Lateralization index 7.4– Right side: 42 versus left side: 5.7
• Right adrenalectomy performed and Conn’s adenoma confirmed• Improvement in ARR one month after operation
Conclusion
• Primary aldosteronism is frequently under-diagnosed in hypertensives
• Aldosterone producing adenoma and bilateral idiopathic hyperaldosteronism are two commonest causes of primary aldosteronism
• Lateralization is important for identification of surgically-amendable causes
Reference• Galati SJ et al. Primary aldosteronism: emerging trends. Trends in
Endocrinology and Metabolism. September 2013, Vol.24, No. 9• Role for adrenal venous sampling in primary aldosteronism. Young
WF et al. Surgery. December 2004.• Schwatz et al. Screening for primary aldosteronism in essential
hypertension: Diagnostic accuracy of the ratio of plasma aldosterone concentration to plasma renin activity. Clinical Chemistry. 51:2. 386-394
• Young WF et al. The incidentally discovered adrenal mass. New England Journal of Medicine 2007; 356: 601-10
• Kahn SL et al. Adrenal vein sampling. Techniques in vascular and interventional radiology 13: 110-125
• Huang YE et al. Role of 131I-NP-59 Adrenal Imaging in Patients of ACTH-Independent Cushing’s Syndrome. Ann Nucl Med Sci 2001;14:75-83
• Chen YC et al. Use of NP-59 SPECT/ CT imaging in atypical primary aldosteronism. Q J Med (2013)
• Rossi GP et al. A Prospective Study of the Prevalence of Primary Aldosteronism in 1125 Hypertensive Patients. JACC vol 48, No 11, 2006
• Moo TA et al. Prediction of Successful Outcome in Patients with Primary Aldosteronism. Current treatment options in oncology (2007) 8:314-321
• Stowasser M et al. Update in Primary aldosteronism. J Clin Endocrinol Metab (2009) 94: 3623-3630
• Liu SYW et al. Radiofrequency ablation for benign aldosterone-producing adenoma: a scarless technique to an old disease. Annals of Surgery 256(6): 1058-1064
• Kempers MJE et al. Systematic Review: Diagnostic Procedures to Differentiate Unilateral From Bilateral Adrenal Abnormality in Primary Aldosteronism. Annals of Internal Medicine, 09/2009, Volume 151, Issue 5, pp. 329 - 337
• American Association of Clinical Endocrinologists and American Association of Endocrine Surgeons Medical Guidelines for the Management of Adrenal Incidentalomas
• The Endocrine Society’s Clinical Guidelines. J Clin Endocrinol Metab 93: 3266-3281, 2008
Thank you
Questions?
Who should be screened?
• Moderate to severe hypertension• Resistant hypertension• Hypertension with a family history of early-onset
disease• Hypertension with an adrenal incidentaloma• History of cerebrovascular accident occurring
before age 40 years• First-degree relative with primary aldosteronism
Galati SJ et al. Primary aldosteronism: emerging trends. Trends in Endocrinology and Metabolism. September 2013, Vol.24, No. 9
Sequelae of primary aldosteronism
Galati SJ et al. Primary aldosteronism: emerging trends. Trends in Endocrinology and Metabolism. September 2013, Vol.24, No. 9
Protocol Interpretation
Intravenous saline load
•Infusion of 2L of 0.9% normal saline over 2 hours
•In recumbent position
PAC > 10ng/dL post-infusion is highly suggestive of PA
Oral salt load •Sodium intake >6g/day for 3 days with diet and sodium chloride tabs
24 hour urinary aldosterone excretion >12μg/day consistent with PA
Captopril challenge test
•25-50mg oral captopril after sitting or standing for 1 hour
ARR >30-50
PAC remained elevated (>8.5ng/dL or greater)
Renin remained suppressed
Fludro-cortisone suppression test
•0.1mg of fludro-cortisone every 6 hours for 4 days
PAC > 6 ng/dL confirms PA
Renin suppressed to <1ng/mL/h
Cortisol measured 10am lower than measured 7-8am
Galati SJ et al. Primary aldosteronism: emerging trends. Trends in Endocrinology and Metabolism. September 2013, Vol.24, No. 9
Drug therapy Drug free
Optimum ratio 95%CI 12.4 (7.1 – 16.6) 14.9 (14.2 – 20.9)
Sensitivity 95%CI 73 87
Specificity 95%CI 74 75
Schwatz et al. Screening for primary aldosteronism in essential hypertension: Diagnostic accuracy of the ratio of plasma aldosterone concentration to plasma renin activity. Clinical Chemistry. 51:2. 386-394